AAAAAA

   
Results: 1-7 |
Results: 7
Interaction of cytosine arabinoside and lovastatin in human leukemia cells
Authors: Holstein, SA Hohl, RJ
Citation: Sa. Holstein et Rj. Hohl, Interaction of cytosine arabinoside and lovastatin in human leukemia cells, LEUK RES, 25(8), 2001, pp. 651-660
Changes in erythropoietin pharmacokinetics following busulfan-induced bonemarrow ablation in sheep: Evidence for bone marrow as a major erythropoietin elimination pathway
Authors: Chapel, S Veng-Pedersen, P Hohl, RJ Schmidt, RL McGuire, EM Widness, JA
Citation: S. Chapel et al., Changes in erythropoietin pharmacokinetics following busulfan-induced bonemarrow ablation in sheep: Evidence for bone marrow as a major erythropoietin elimination pathway, J PHARM EXP, 298(2), 2001, pp. 820-824
Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial
Authors: Karp, JE Lancet, JE Kaufmann, SH End, DW Wright, JJ Bol, K Horak, I Tidwell, ML Liesveld, J Kottke, TJ Ange, D Buddharaju, L Gojo, I Highsmith, WE Belly, RT Hohl, RJ Rybak, ME Thibault, A Rosenblatt, J
Citation: Je. Karp et al., Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial, BLOOD, 97(11), 2001, pp. 3361-3369
2-(acyloxy)ethylphosphonate analogues of prenyl pyrophosphates: Synthesis and biological characterization
Authors: Cermak, DM Wiemer, DF Lewis, K Hohl, RJ
Citation: Dm. Cermak et al., 2-(acyloxy)ethylphosphonate analogues of prenyl pyrophosphates: Synthesis and biological characterization, BIO MED CH, 8(12), 2000, pp. 2729-2737
Synthesis of phosphonate derivatives of uridine, cytidine, and cytosine arabinoside
Authors: Jung, KY Hohl, RJ Wiemer, AJ Wiemer, DF
Citation: Ky. Jung et al., Synthesis of phosphonate derivatives of uridine, cytidine, and cytosine arabinoside, BIO MED CH, 8(10), 2000, pp. 2501-2509
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
Authors: Yung, WKA Albright, RE Olson, J Fredericks, R Fink, K Prados, MD Brada, M Spence, A Hohl, RJ Shapiro, W Glantz, M Greenberg, H Selker, RG Vick, NA Rampling, R Friedman, H Phillips, P Bruner, J Yue, N Osoba, D Zaknoen, S Levin, VA
Citation: Wka. Yung et al., A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse, BR J CANC, 83(5), 2000, pp. 588-593
Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: Cancer and leukemia group B study 9473
Authors: Burns, CP Halabi, S Clamon, GH Hars, V Wagner, BA Hohl, RJ Lester, E Kirshner, JJ Vinciguerra, V Paskett, E
Citation: Cp. Burns et al., Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: Cancer and leukemia group B study 9473, CLIN CANC R, 5(12), 1999, pp. 3942-3947
Risultati: 1-7 |